Objective
The overall objective is to advance knowledge and technologies to model intestinal dysbiosis in vitro at different levels, in order to provide tools that make it possible to assess or design prevention and/or therapeutic strategies aimed at restoring microbiota balance and, consequently, recovering healthy functioning of the body’s physiological conditions. The scope of the project applies to companies in the nutraceutical, food, pharmaceutical and biotechnology sectors.
Activities
- Optimisation of the dynamic in vitro simulation of the state of dysbiosis
- Application of procedures and technologies to support therapies or treatments based on faecal microbiota transplantation
- Development of in vitro models of intestinal dysbiosis related to the Gut-Microbiota-Brain axis
- Technology transfer
- Management and coordination
- Dissemination and communication
Dissemination/Transfer
Press releases
Twelve new R&D projects with the support of IVACE
AINIA develops in vitro models for the design of strategies to improve intestinal health
Development of in vitro models to create effective solutions against intestinal dysbiosis
Dissemination articles
Intestinal dysbiosis: how we are advancing in experimental models to improve health
Microbiota and intestinal dysbiosis: applied science to improve digestive and mental health
DISBIOSIS Project
Photos
DISBIOSIS project photo session
Video
Intestinal dysbiosis: in vitro and organ-on-chip models for validated products
